Comparing the duration of spinal anesthesia with bupivacaine between drug-dependent and non-dependent patients
Open Access
- 4 October 2018
- journal article
- research article
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 5 (10) , 2721-2725
Abstract
Background & Aim: Drug abusers have much lower pain threshold, in a way that the duration of the effect of anesthesia on controlling their pain is still not fully known. Therefore, this study aimed to compare the duration of spinal anesthesia induced with bupivacaine between drug-dependent and non-dependent individuals. Methods: This quasi-experimental study was conducted on two 60-member groups consisting of drug-dependent and non-dependent patients undergoing lowerlimb orthopedic surgery. Patients were selected via simple convenience sampling and underwent a similar procedure of spinal anesthesia using the same needle and medicine by an anesthesiologist, who was unaware of the patients' placement in the study groups. After surgery, the duration of patients' anesthesia was correspondingly measured in both groups and compared using the independent t-test. Results: In this research study, no significant difference was observed between the groups in terms of age and gender. The mean duration of opium abuse in the drug-dependent patient group was reported to be 7.5+/-1.3 years. In addition, the duration of spinal anesthesia in the drug-dependent patient group was shorter, compared to the non-dependent group (P=0.0001). Conclusion: According to the results of the study, intrathecal bupivacaine is not a durable anesthesia, for performing surgeries that might last more than an hour, in drug-dependent patients.Keywords
This publication has 18 references indexed in Scilit:
- Evaluation of spinal anesthesia blockade time with 0.5% hyperbaric bupivacaine, with or without sufentanil, in chronic opioid users: a randomized clinical trialBrazilian Journal of Anesthesiology (English Edition), 2016
- Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockadeNature Medicine, 2015
- Involvement of neuronal TGF‐β activated kinase 1 in the development of tolerance to morphine‐induced antinociception in rat spinal cordBritish Journal of Pharmacology, 2015
- Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathwaysPain, 2007
- Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate deliveryNeuroscience Letters, 2006
- Role of NK-1 neurotransmission in opioid-induced hyperalgesiaPain, 2005
- Underlying mechanisms of pronociceptive consequences of prolonged morphine exposurePeptide Science, 2005
- Voltage‐gated sodium channels and pain pathwaysJournal of Neurobiology, 2004
- Endogenous Opioid Peptides Contribute to Antinociceptive Potency of Intrathecal [Dmt1]DALDAThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugsEuropean Journal of Anaesthesiology, 1997